{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:47:43Z","timestamp":1790099263935,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00800","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T23:25:10Z","timestamp":1509924310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies"],"prefix":"10.3389","volume":"8","author":[{"given":"Yu-Hsiao","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jou","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ping","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Cheng","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2152\/jmi.57.163","article-title":"Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer","volume":"57","author":"Abe","year":"2010","journal-title":"J. Med. Invest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ygyno.2016.09.027","article-title":"Platinum desensitization in patients with carboplatin hypersensitivity: a single-institution retrospective study. Gynecol","volume":"144","author":"Altwerger","year":"2017","journal-title":"Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2217\/imt.14.71","article-title":"Carboplatin hypersensitivity: evaluation and successful desensitization protocol","volume":"6","author":"Bruchim","year":"2014","journal-title":"Immunotherapy"},{"key":"B4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3802\/jgo.2013.24.4.342","article-title":"Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan","volume":"24","author":"Chiang","year":"2013","journal-title":"J. Gynecol. Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/cncr.21168","article-title":"Successful carboplatin desensitization in patients with proven carboplatin allergy","volume":"104","author":"Confino-Cohen","year":"2005","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/gyno.2001.6519","article-title":"Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy","volume":"84","author":"Dizon","year":"2002","journal-title":"Gynecol. Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1525-1438.2007.01063.x","article-title":"Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer","volume":"18","author":"Gadducci","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00520-011-1123-y","article-title":"Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma","volume":"20","author":"Genc","year":"2012","journal-title":"Supportive. Care. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/IGC.0b013e3181a418ff","article-title":"Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study","volume":"19","author":"Gomez","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00280-009-1159-6","article-title":"Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report","volume":"66","author":"Greene","year":"2010","journal-title":"Cancer. Chemother. Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/cas.12538","article-title":"Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and Fc\u03b5RI","volume":"105","author":"Iwamoto","year":"2014","journal-title":"Cancer Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1525-1438.2005.00136.x","article-title":"Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity","volume":"15","author":"Kandel","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/IGC.0b013e3181a1bf2e","article-title":"Incidence of carboplatin-related hypersensitivity reactions in Japanese patients with gynecologic malignancies","volume":"19","author":"Koshiba","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/annonc\/mdt333","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Ledermann","year":"2013","journal-title":"Ann. Oncol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/030089160308900315","article-title":"Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases","volume":"89","author":"Libra","year":"2003","journal-title":"Tumori"},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ygyno.2007.06.016","article-title":"The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer management","volume":"107","author":"Markman","year":"2007","journal-title":"Gynecol. Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J. Clin. Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/bjc.2013.389","article-title":"Deleterious BRCA1\/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions","volume":"109","author":"Moon","year":"2013","journal-title":"Br. J. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol. Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel on patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy vs. conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: An intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","volume":"24","author":"Pfisterer","year":"2006","journal-title":"J. Clin. Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000055363","article-title":"Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience","volume":"61","author":"Polyzos","year":"2001","journal-title":"Oncology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1200\/JCO.2009.25.7519","article-title":"Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse","volume":"28","author":"Pujade-Lauraine","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ygyno.2006.10.047","article-title":"Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital","volume":"105","author":"Schwartz","year":"2007","journal-title":"Gynecol. Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/pbc.25697","article-title":"Carboplatin rechallenge after hypersensitivity reactions in pediatric patients with low-grade glioma","volume":"63","author":"Shah","year":"2016","journal-title":"Pediatric. Blood. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA. Cancer. J. Clin"},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1048-891x.2005.14401.x","article-title":"Carboplatin hypersensitivity","volume":"15","author":"Sliesoraitis","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10147-014-0731-1","article-title":"4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study","volume":"20","author":"Takase","year":"2015","journal-title":"Int. J. Clin. Oncol"},{"key":"B30","first-page":"4525","article-title":"Hypersensitivity reactions associated with platinum-containing antineoplastic agents for thoracic malignancies","volume":"31","author":"Tamiya","year":"2011","journal-title":"Anticancer. Res"},{"key":"B31","first-page":"837","article-title":"Clinical analysis of thirteen cases of hypersensitivity reactions to carboplatin","volume":"44","author":"Wang","year":"2009","journal-title":"Zhonghua. Fu. Chan. Ke. Za. Zhi"},{"key":"B32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/gyno.1994.1098","article-title":"Death from anaphylaxis to cisplatin: a case report","volume":"53","author":"Zweizig","year":"1994","journal-title":"Gynecol. Oncol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T13:01:47Z","timestamp":1570280507000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,6]]},"references-count":32,"alternative-id":["10.3389\/fphar.2017.00800"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00800","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,6]]},"article-number":"800"}}